Please assess the completion status of the following clinical trial:

Trial Title: Prednisolone vs. Ciclosporine in Severe Atopic Eczema

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* male and female patients age \>= 18 and \< 55~* weight between 50 and 100 kg~* confirmed diagnosis of AE (UK working party criteria)~* objective SCORAD \> 40~* DLQI \> 10~* resistancy against topical treatment options including steroids and calcineurin-inhibitors~Exclusion Criteria:~* participation to another clinical trial within the last 4 weeks before baseline~* pregnant or breastfeeding~* women of childbearing potential without adequate contraception~* allergy against prednisolone or Ciclosporine A~* acute bacterial or viral infection~* malignant tumor in personal history~* diabetes mellitus~* arterial hypertension~* Glaucoma~* peptic ulcer~* severe osteoporosis~* tuberculosis in personal history~* colitis ulcerosa~* diverticulitis~* concurrent treatment with chloroquin, Mefloquin, Statins, Warafin~* Creatinin Clearance \< 60 ml /min~* UV treatment within 8 weeks before inclusion~* ongoing systemic immunosuppressive treatment~* planned vaccination within 8 weeks before study entry, during study and 2 weeks after end of study~* Poliomyelitis~* Lymphadenitis after BCG vaccination~* Hyperuricaemia~* chronic liver disease~* Xeroderma pigmentosum, Cockaye-Syndrome, Bloom Syndrome~* Psychiatric co-morbidity~* drug or alcohol abuse

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): None
- 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).